# Vyvanse in Children Aged 6 to 12 Years

> **NCT05416125** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Minnesota** · enrollment: 44 (actual)

## Conditions studied

- Obesity, Childhood

## Interventions

- **DRUG:** Lisdexamfetamine Dimesylate
- **BEHAVIORAL:** Lifestyle therapy

## Key facts

- **NCT ID:** NCT05416125
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-12-20
- **Primary completion:** 2026-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05416125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05416125, "Vyvanse in Children Aged 6 to 12 Years". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05416125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*